Management of Severe Hyperglycemia

Initial Assessment and Treatment Strategy

For a patient with an HbA1c of 12.8%, immediate initiation of combination therapy with metformin plus a second agent is strongly recommended, with consideration of insulin therapy due to the severely elevated glycemic level, according to the American College of Physicians 1, 2, 3
An HbA1c of 12.8% indicates severe hyperglycemia with an estimated average blood glucose of approximately 345 mg/dL, indicating urgent need for glycemic control, as stated by the American Diabetes Association 4
This level of hyperglycemia significantly increases risk of both microvascular and macrovascular complications, requiring prompt and effective intervention, as recommended by the American College of Physicians 3
Treatment decisions should be based on the patient's overall health status and comorbidities, life expectancy, and patient preferences regarding medication administration, according to the American College of Physicians 1, 2

Start metformin (if not contraindicated) as first-line therapy, as recommended by the American College of Physicians 2, 3
Simultaneously initiate a second agent due to the severely elevated HbA1c, according to the American Diabetes Association 3
Consider insulin therapy, particularly if patient is symptomatic (polyuria, polydipsia, weight loss), as suggested by the American College of Physicians 2
For HbA1c >9%, combination therapy options include metformin plus basal insulin, as recommended by the American College of Physicians 2, 3

Initial target should be to reduce symptoms of hyperglycemia and bring HbA1c below 9%, according to the American College of Physicians 2, 5
Long-term target should be HbA1c <7% for most patients without significant comorbidities, as recommended by the American Diabetes Association 1, 3
Monitor HbA1c every 3 months until target is achieved, then at least twice yearly if stable, as suggested by the American Diabetes Association 4

Less aggressive targets (HbA1c <8%) may be appropriate for older adults (>80 years), patients with limited life expectancy (<10 years), or those with significant comorbidities or history of severe hypoglycemia, according to the American College of Physicians 1, 2, 5

The American Diabetes Association recommends an HbA1c target of <7% for most non-pregnant adults, with more or less stringent goals based on individual factors, as stated by the American Diabetes Association 1
The American College of Physicians suggests a target between 7-8% for most adults with type 2 diabetes, according to the American College of Physicians 2, 5